Significant pathways [39/95] pathways contains significant subpathways MAPK signaling pathway (hsa04010)
ErbB signaling pathway (hsa04012)
Chemokine signaling pathway (hsa04062)
Cell cycle (hsa04110)
Oocyte meiosis (hsa04114)
Apoptosis (hsa04210)
Wnt signaling pathway (hsa04310)
Axon guidance (hsa04360)
VEGF signaling pathway (hsa04370)
Focal adhesion (hsa04510)
NOD-like receptor signaling pathway (hsa04621)
Jak-STAT signaling pathway (hsa04630)
Natural killer cell mediated cytotoxicity (hsa04650)
T cell receptor signaling pathway (hsa04660)
B cell receptor signaling pathway (hsa04662)
Fc epsilon RI signaling pathway (hsa04664)
Fc gamma R-mediated phagocytosis (hsa04666)
Neurotrophin signaling pathway (hsa04722)
Olfactory transduction (hsa04740)
Regulation of actin cytoskeleton (hsa04810)
Insulin signaling pathway (hsa04910)
GnRH signaling pathway (hsa04912)
Adipocytokine signaling pathway (hsa04920)
Alzheimer's disease (hsa05010)
Amyotrophic lateral sclerosis (ALS) (hsa05014)
Bacterial invasion of epithelial cells (hsa05100)
Vibrio cholerae infection (hsa05110)
Leishmaniasis (hsa05140)
Chagas disease (hsa05142)
Pathways in cancer (hsa05200)
Colorectal cancer (hsa05210)
Renal cell carcinoma (hsa05211)
Glioma (hsa05214)
Prostate cancer (hsa05215)
Melanoma (hsa05218)
Chronic myeloid leukemia (hsa05220)
Acute myeloid leukemia (hsa05221)
Small cell lung cancer (hsa05222)
Non-small cell lung cancer (hsa05223)
Drug repurposing [?]
None
Drugbank (The triangular compound term that is associated
with greater than or equal to genes)
Drugbank w/ drug-likeness (The triangular compound term that is associated
with greater than or equal to genes)
PharmGKB (The triangular drug term that is associated
with greater than or equal to genes)
PharmGKB w/ drug-likeness (The triangular drug term that is associated
with greater than or equal to genes)
Diseases (HGMD) (The triangular disease term that is
associated with greater than or equal to genes)
All rights reserved to BIBS laboratory, Seoul National University, Korea. |